Free Trial
NASDAQ:SLXN

Silexion Therapeutics (SLXN) Stock Price, News & Analysis

Silexion Therapeutics logo
$7.18 +0.38 (+5.59%)
Closing price 03:58 PM Eastern
Extended Trading
$6.88 -0.30 (-4.23%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Silexion Therapeutics Stock (NASDAQ:SLXN)

Key Stats

Today's Range
$6.66
$7.23
50-Day Range
$6.80
$14.94
52-Week Range
$6.51
$236.25
Volume
26,166 shs
Average Volume
149,656 shs
Market Capitalization
$4.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.00
Consensus Rating
Buy

Company Overview

Silexion Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

SLXN MarketRank™: 

Silexion Therapeutics scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Silexion Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Silexion Therapeutics has received no research coverage in the past 90 days.

  • Read more about Silexion Therapeutics' stock forecast and price target.
  • Short Interest

    There is no current short interest data available for SLXN.
  • Dividend Yield

    Silexion Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Silexion Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for SLXN.
  • News Sentiment

    Silexion Therapeutics has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Silexion Therapeutics this week, compared to 1 article on an average week.
  • Search Interest

    Only 6 people have searched for SLXN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Silexion Therapeutics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Silexion Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.00% of the stock of Silexion Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 10.95% of the stock of Silexion Therapeutics is held by institutions.

  • Read more about Silexion Therapeutics' insider trading history.
Receive SLXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SLXN Stock News Headlines

Silexion Therapeutics Increases Authorized Share Capital
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel
See More Headlines

SLXN Stock Analysis - Frequently Asked Questions

Silexion Therapeutics' stock was trading at $30.15 at the beginning of the year. Since then, SLXN shares have decreased by 76.2% and is now trading at $7.18.

Silexion Therapeutics Corp (NASDAQ:SLXN) posted its quarterly earnings results on Tuesday, August, 12th. The company reported ($4.32) earnings per share for the quarter, missing the consensus estimate of ($3.15) by $1.17.

Shares of Silexion Therapeutics reverse split on Sunday, July 27th 2025.The 1-15 reverse split was announced on Sunday, July 27th 2025. The number of shares owned by shareholders was adjusted after the market closes on Sunday, July 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of SLXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Silexion Therapeutics investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
8/12/2025
Today
8/22/2025
Next Earnings (Estimated)
9/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLXN
Previous Symbol
NASDAQ:SLXN
CIK
2022416
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$75.00
Low Price Target
$75.00
Potential Upside/Downside
+944.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-355.74%

Debt

Debt-to-Equity Ratio
26.58
Current Ratio
2.44
Quick Ratio
2.44

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.21 per share
Price / Book
34.19

Miscellaneous

Outstanding Shares
580,000
Free Float
545,000
Market Cap
$4.16 million
Optionable
N/A
Beta
0.08

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SLXN) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners